Back to Agenda
Session 2: Adaptive Pathways and Innovative Medicines Development for Improved Access
Session Chair(s)
Solange Corriol-Rohou, DrMed, MD, PhD
Senior Director, Global Regulatory Affairs & Policy, R&D, Europe
AstraZeneca , France
Speaker(s)
Adaptive Pathways: An HTA Perspective: Jacoline Bouvy, PhD
Scientific Adviser, Science Policy and Research Programme
National Institute for Health and Care Excellence (NICE), United Kingdom
Adaptive Pathways: An Industry’s Perspective: Claudine Sapède, PharmD
Director, Global HTA Policy
NOVARTIS INTERNATIONAL, Switzerland
Richard Barker, PhD
Founding Director
Centre for the Advancement of Sustainable Medical Innovation (CASMI), United Kingdom
Adaptive Pathways: A Clinician's Perspective: Rosa Giuliani, MD
Consultant in Medical Oncology, S. Camillo-Forlanini Hospital, Italy
European Society for Medical Oncology (ESMO), Switzerland
Have an account?